An artificial alternative to antibiotics has been developed to fight hospital superbugs such as MRSA, according to an article on Forbes.com. The drug, Staphefekt, is reported to be the first new type of weapon to be added to the medical arsenal against infection in a quarter of a century.
Five out of six patients with MRSA (methicillin-resistant Staphylococcus aureus) skin infections were cured in a small-scale trial at the Public Health Laboratory in Kennemerland, the Netherlands, scientists reported at the Antibiotic Alternatives for the New Millennium conference in London yesterday, on Nov. 5.
Click here to read the entire article.
Source: Forbes.com
Latest from Quality Assurance & Food Safety
- USDA Indefinitely Delays Salmonella Testing Program for Raw Breaded Stuffed Chicken
- American Soybean Association Names New Industry Relations Leadership
- Babybel Transitions From Cellophane to Paper Packaging
- Ambriola Company Recalls Cheese Products Due to Listeria Risk
- Horizon Family Brands Acquires Maple Hill Creamery
- Kellanova Shares Top Five Consumer Packaged Goods Tech Trends Shaping 2026
- Stay Ahead of Supply Chain Pressure
- Brendan Niemira Named IFT Chief Science and Technology Officer
